irbesartan (Avapro)
Title: irbesartan (Avapro)Category: MedicationsCreated: 6/6/1999 12:00:00 AMLast Editorial Review: 2/28/2019 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - February 28, 2019 Category: Cardiology Source Type: news

Class 2 Medicines recall: Actavis Group Irbesartan Film-coated tablets
... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 13, 2019 Category: Drugs & Pharmacology Source Type: news

Cancer Fears Have Triggered Blood Pressure Drug Recalls for Months. Now Patients Are ‘Leery’
Cynthia Brown had been taking the drug valsartan for about two years when she learned last August that it had been recalled over fears of potential carcinogen contamination. Brown, a writer and patient advocate living near Cincinnati, had been prescribed valsartan to control shortness of breath related to primary pulmonary hypertension, but suddenly she had a whole new concern: cancer. “I’ve always been very conscientious about my health. I never dreamed I’d be on all these medications, and I’m real funny about what I take,” Brown, 65, says. “Valsartan has made me leery of all medication...
Source: TIME: Health - January 29, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Drugs healthytime Source Type: news

2 MILLION people have been exposed to cancer-causing chemicals in contaminated blood pressure drugs
Last summer, it emerged widely-prescribed drugs for heart failure and hypertension - including  valsartan and irbesartan - had dangerously high levels of recognized carcinogens. (Source: the Mail online | Health)
Source: the Mail online | Health - January 26, 2019 Category: Consumer Health News Source Type: news

Health officials announce ANOTHER recall of blood pressure pills in the UK
Today's announcement concerns irbesartan supplied by Macleods Pharma UK, while other recalls have involved the company Actavis. (Source: the Mail online | Health)
Source: the Mail online | Health - January 24, 2019 Category: Consumer Health News Source Type: news

Class 2 Medicines Recall: Macleods Pharma UK Limited - Irbesartan Film-coated tablets
Macleods Pharma UK Limited is recalling some batches of Irbesartan 150mg and 300mg Film-coated tablets from pharmacies. This is a precautionary measure due to possible risk of contamination with N ‑nit (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 24, 2019 Category: Drugs & Pharmacology Source Type: news

ANOTHER batch of blood pressure drugs recalled over traces of cancer-causing chemical
Earlier this month, EU regulators recalled Irbesartan over NDEA fears. On Monday, a US firm followed suit. It is part of a months-long global recall tied to contaminated China-made drugs. (Source: the Mail online | Health)
Source: the Mail online | Health - January 23, 2019 Category: Consumer Health News Source Type: news

FDA: Irbesartan lots recalled over likely carcinogen
A drug company has recalled more irbesartan blood pressure medication after discovering a potential human carcinogen. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 19, 2019 Category: Consumer Health News Source Type: news

Prinston Pharmaceutical Inc. issues Voluntary Nationwide Recall of Irbesartan and Irbesartan HCTZ Tablets Due to detection of a Trace Amount of Unexpected Impurity, N- nitrosodiethylamine (NDEA) in the Products
-- Prinston Pharmaceutical Inc., dba Solco Healthcare LLC., has initiated a voluntary recall of one (1) lot of Irbesartan and seven (7) lots of Irbesartan HCTZ Tablets to the consumer level due to the detection of trace amount of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Zhejiang Huahai Pharmaceuticals. (Source: Food and Drug Administration)
Source: Food and Drug Administration - January 18, 2019 Category: Food Science Source Type: news

Some irbesartan medicines recalled
MHRA recall some blood pressure and heart medication because of contamination fears Related items fromOnMedica Blood pressure measurement Hypertension: what ’s new and how might this impact practice? Withdrawn valsartan meds not linked to short-term cancer risk Exercise may be as good at lowering blood pressure as drugs Treatment of hypertension for low-risk patients questioned (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 7, 2019 Category: UK Health Source Type: news

Heart Drug Recall Expanded Again
(CNN) — The recall of popular heart drugs has expanded yet again. The US Food and Drug Administration said Thursday that Torrent Pharmaceuticals has added eight additional lots of losartan potassium tablets to its recall list. Losartan potassium is a drug used to control high blood pressure. It is also used to treat kidney disease in patients with diabetes. This recall includes 30-, 90- and 1,000-count bottles of 100-milligram tablets; 30-, 90- and 1,000-count bottles of 50-milligram tablets; and 90-count bottles of 25-milligram tablets. Torrent is recalling only these particular losartan potassium tablets. Tests fou...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 4, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Recall Valsartan Source Type: news

Thousands MORE blood pressure pills are recalled
The Medicines and Healthcare products Regulatory Agency, which polices the safety of medical products in the UK, issued the alert over four irbesartan products. (stock) (Source: the Mail online | Health)
Source: the Mail online | Health - January 3, 2019 Category: Consumer Health News Source Type: news

Class 2 Medicines Recall: Actavis Group PTC EHF - recall of some batches of Irbesartan/Hydrochlorothiazide 300/12.5mg Film-coated Tablets and Irbesartan/Hydrochlorothiazide 150/12.5mg Film-coated Tablets
Specific batches of Irbesartan/Hydrochlorothiazide 300/12.5mg Film-coated Tablets and Irbesartan/Hydrochlorothiazide 150/12.5mg Film-coated Tablets, made by Actavis (now Accord), are being recalled as (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 3, 2019 Category: Drugs & Pharmacology Source Type: news

Do Neprilysin Inhibitors Have a Role in Patients With CKD? Do Neprilysin Inhibitors Have a Role in Patients With CKD?
Dr Desai reviews the UK HARP-III trial, which compares the effects of sacubitril/valsartan and irbesartan on kidney function in people with CKD.Medscape Nephrology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 14, 2018 Category: Consumer Health News Tags: Nephrology Viewpoint Source Type: news

Blood Pressure Drug Recall Expands Again; Meds May Be Tainted With Cancer-Causing Chemical
(CNN) — The US Food and Drug Administration says another heart medicine is being voluntarily recalled after tests showed that it was tainted with a potential cancer-causing chemical. The recall includes one lot of Sandoz’s losartan potassium hydrochlorothiazide 100 milligram/25 milligram tablets with the lot number JB8912. Patients use these drugs to keep their high blood pressure in check. The drug is being recalled because the active ingredient has tested positive for N-Nitrosodiethylamine or NDEA, a suspected human and animal carcinogen that is used in gasoline as a stabilizer for industry materials and as a...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 12, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News Local TV Valsartan Source Type: news

Aurobindo recalls hypertensive drug in US citing cancer risk
ScieGen Pharmaceuticals has initiated recall of the finished Irbesartan drug from the market, a separate notification by the FDA said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 4, 2018 Category: Pharmaceuticals Source Type: news

Blood Pressure Medication Recall: What Is In This That May Cause Cancer?
The FDA announced that Sciegen Pharmaceuticals, Inc. is voluntarily recalling irbesartan tablets. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 2, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Blood pressure drug Irbesartan recalled over potentially cancerous impurity
A pharmaceutical company is recalling a blood pressure medication because it could contain an impurity scientists believe could cause cancer. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 2, 2018 Category: Consumer Health News Source Type: news

FDA Issues Alert on Blood Pressure Drug Irbesartan
FDA Issues Alert on Irbesartan Due to Contamination (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - November 2, 2018 Category: General Medicine Source Type: news

FDA Issues Alert on Recalled Irbesartan Due to Contamination FDA Issues Alert on Recalled Irbesartan Due to Contamination
Testing confirmed the presence of the impurity NDEA in recalled lots of irbesartan from SciGen Pharmaceuticals and in the active substance supplied to the US market by Aurobindo Pharma.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 1, 2018 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news

FDA Issues Alert on Irbesartan Due to Contamination FDA Issues Alert on Irbesartan Due to Contamination
Testing confirmed the presence of the impurity NDEA in recalled lots of irbesartan from SciGen Pharmaceuticals and in the active substance supplied to the US market by Aurobindo Pharma.News Alerts (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 1, 2018 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news

Second Hypertension Drug Recalled Due to Contamination
THURSDAY, Nov. 1, 2018 -- Another hypertension drug is being recalled due to contamination that could pose a cancer risk, the U.S. Food and Drug Administration says. Certain lots of irbesartan are being recalled by SciGen because they contain an... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 1, 2018 Category: Pharmaceuticals Source Type: news

FDA Announces Recall Of Another Heart Medicine For Possible Cancer Risk
(CNN) — The US Food and Drug Administration is alerting patients of another recall of medicine used to treat high blood pressure, for a potential cancer risk due to contamination. This time, SciGen is recalling certain lots of irbesartan. The recalled lot will have “Westminster Pharmaceuticals” and “GSMS Inc.” on the label, according to the FDA list. Another heart medicine, valsartan, has also been recalled recently due to contamination. Irbesartan is an angiotensin II receptor blocker, or ARB. This is a drug that blocks a potent chemical in the blood called anigiotensin, which causes muscles ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 1, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Local TV Recall Source Type: news

FDA announces recall of another heart medicine for possible cancer risk
The US Food and Drug Administration is alerting patients of another recall of medicine used to treat high blood pressure, for a potential cancer risk due to contamination. This time, SciGen is recalling certain lots of irbesartan. (Source: CNN.com - Health)
Source: CNN.com - Health - October 31, 2018 Category: Consumer Health News Source Type: news

FDA: Irbesartan Under Recall Too in the Midst of Valsartan Saga
(MedPage Today) -- Another ARB found to contain a potential carcinogen in some lots (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 31, 2018 Category: American Health Source Type: news

Sciegen Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Irbesartan Tablets, USP 75 Mg, 150 Mg, and 300 Mg Due to The Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in The Active Pharmaceutical Ingredient (API)
ScieGen Pharmaceuticals, Inc. is voluntarily recalling listed lots, within expiry, of Irbesartan Tablets, USP 75 mg, 150 mg, and 300 mg dosage forms to the consumer level. These products are being recalled due to the presence of an impurity, N-nitrosodiethylamine (NDEA) contained in the API Irbesartan, USP manufactured by Aurobindo Pharma Limited. This impurity, which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) (Source: Food and Drug Administration)
Source: Food and Drug Administration - October 30, 2018 Category: Food Science Source Type: news

Aurobindo Pharma Limited Issues Voluntary Recall of Irbesartan Drug Substance due to the Detection of Trace Amounts of NDEA (NNitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient (API)
Aurobindo Pharma Limited is voluntarily recalling 22 Batches of the drug substance Irbesartan due to the presence of an impurity, N-nitrosodiethylamine (NDEA). The impurity, which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC). (Source: Food and Drug Administration)
Source: Food and Drug Administration - October 29, 2018 Category: Food Science Source Type: news

EMA Takes Further Action in Ongoing Review of Tainted'Sartans'EMA Takes Further Action in Ongoing Review of Tainted'Sartans '
The European Medicines Agency (EMA) has placed Zheijiang Huahai Pharmaceuticals under increased supervision and stopped Aurobindo Pharma from supplying irbesartan to the European Union.News Alerts (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 15, 2018 Category: Pathology Tags: Cardiology News Alert Source Type: news

AIMS: Irbesartan Slows Marfan's Aortic Dilatation, Lower BP Key? AIMS: Irbesartan Slows Marfan's Aortic Dilatation, Lower BP Key?
Also, should beta-blockers be added to angiotensin receptor blockade in Marfan syndrome? It's possible there may be synergy between the two,'but we didn't see any sign of that,'researchers say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 5, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

ESC: Irbesartan Slows Aortic Dilation in Marfan Syndrome
(MedPage Today) -- ARB therapy yielded 30% reduction in growth rate (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 28, 2018 Category: Cardiology Source Type: news

Irbesartan Generic Tablets (irbesartan) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2017 Category: Drugs & Pharmacology Source Type: news

The 'Obamacare' Deadline Is Approaching. Here's What You Need to Know Before Signing Up
By Lacie Glover Here's one resolution you should check off early in the year: choosing a health plan if you don't already have one. The deadline to buy a plan under the Affordable Care Act mandate is Jan. 31. If you don't choose a plan by the deadline and pay the first payment when it's due, you won't be able to get coverage this year, with few exceptions. If you lack health coverage for more than three full, consecutive calendar months in any year, you could have to pay a tax penalty. There's a good chance that "Obamacare" will be repealed or revised in 2017, but it's still in place now, so the...
Source: Healthy Living - The Huffington Post - January 3, 2017 Category: Consumer Health News Source Type: news

Avalide (Irbesartan-Hydrochlorothiazide) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 12, 2016 Category: Drugs & Pharmacology Source Type: news

Irbesartan and Hydrochlorothiazide Tablets USP (New - Discontinuation)
Updated Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - November 18, 2016 Category: Drugs & Pharmacology Source Type: news

Avapro (Irbesartan) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 20, 2016 Category: Drugs & Pharmacology Source Type: news

Global Health: Common Blood-Pressure Drug May Work on Malaria, Too
Giving malaria victims a common blood-pressure drug along with regular treatment may save help lives, a mouse study suggests. (Source: NYT Health)
Source: NYT Health - September 19, 2016 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Malaria irbesartan Avapro Journal of Clinical Investigation Rodriguez, Ana Source Type: news

Gene expression analysis points metastatic CRC patient to successful irbesartan therapy
medwireNews: A patient with recurrent metastatic colorectal cancer has been successfully treated with the angiotensin receptor blocker irbesartan, researchers report. (Source: MedWire News)
Source: MedWire News - February 25, 2016 Category: Consumer Health News Tags: Colorectal cancer Source Type: news

Second Hypertension Drug Recalled Due to Contamination
Some lots of irbesartan being recalled due to contamination with suspected carcinogen (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 11, 2014 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Nursing, Oncology, Pharmacy, Institutional, Source Type: news

Diabetics Taking Certain Blood Pressure Drugs At Lower Risk Of Heart Disease
Two drugs, telmisartan and valsartan, which are used to reduce blood pressure in people with diabetes, are associated with a lower risk of hospitalization for heart attack, stroke or heart failure, according to a study published in CMAJ (Canadian Medical Association Journal). For people with type 2 diabetes, disease-related vascular illnesses are the main causes of death. Angiotensin-receptor blockers including telmisartan, valsartan, candesartan, irbesartan and losartan, are generally used interchangeably to control blood pressure... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 10, 2013 Category: Consumer Health News Tags: Hypertension Source Type: news

Two ARBs Lower Risk of CVD Complications in DiabeticsTwo ARBs Lower Risk of CVD Complications in Diabetics
Compared with irbesartan, the use of telmisartan and valsartan lowered the risk of hospital admission for MI, stroke, or heart failure by 15% and 14%, respectively. The reduction was driven primarily by a reduction in the risk of heart-failure hospitalizations. Heartwire (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 8, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news

Telmisartan, valsartan lower risk of CVD complications in diabetics
Compared with irbesartan, the use of telmisartan and valsartan lowered the risk of hospital admission for MI, stroke, or heart failure by 15% and 14%, respectively. The reduction was driven primarily by a reduction in the risk of heart-failure hospitalizations. (Source: theHeart.org)
Source: theHeart.org - July 8, 2013 Category: Cardiology Source Type: news